Brexanolone

(Zulresso®)

Brexanolone

Drug updated on 11/14/2023

Dosage FormInjection (intravenous; 5 mg/mL)
Drug ClassNeuroactive steroid gamma-aminobutyric acid A receptor positive modulators
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of postpartum depression (PPD) in patients 15 years and older.